Y
Youzhiyou Biopharmaceutical
A biotechnology company that develops anti-tumor bispecific antibodies
About Youzhiyou Biopharmaceutical
YZY Biopharma is a biotechnology company specializing in the development of bispecific antibodies aimed at enhancing T cell infiltration and antitumor activity, particularly for triple-negative breast cancer. Operating in the biopharmaceutical sector, YZY Biopharma serves clients in the healthcare and medical research industries, focusing on innovative immunotherapy solutions. The company's business model revolves around the research, development, and commercialization of advanced therapeutic antibodies. Revenue is generated through partnerships, licensing agreements, and direct sales of their proprietary biopharmaceutical products. YZY Biopharma's market includes both China and the United States, where it leverages cutting-edge technology and scientific research to address unmet medical needs in oncology and immunotherapy.
Source: Dealroom company dataNews
Open roles
Youzhiyou Biopharmaceutical in the Wuhan ecosystem
The Youzhiyou Biopharmaceutical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
- HIHubei Science and Technology Investment
- WHWuhan Hi-Tech
- WGWuhan Optics Valley Financial Holding Group
Source: Dealroom Talent Intelligence.
See Youzhiyou Biopharmaceutical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


